Die beiden Neuinvestoren komplettieren die Seed-Finanzierung. Mit dem nun eingeworbenen Kapital plant Redwave den Abschluss der invasiven Validierungsstudie und den Markteintritt in 2019!
We deliver the first algorithm for everybody to:
Benefit from a faster and more successful hypertension therapy.
Get all the information you were always looking for about your health status.
Monitor your health now and have a safe and healthy life.
(53, General Practitioner)
“I’m really looking forward to get the Redwave product. Finally, I can optimize the treatment of my hypertension patients.”
(37, Construction Engineer)
“Almost all of my family is suffering from high blood pressure. With Redwave I can detect my own risk way earlier.”
“I have high blood pressure for 5 years. Although I take my meds, I’m afraid to get a heart attack. With Redwave I can control my risk.”